Magnasense Press Releace

Investors

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

2022-10-24 16:58 AegirBio has received approval from the Notified Body to prolong the shelf life of its Covid-19 antigen test Regulatory MAR
2022-10-24 16:58 AegirBio har fått godkännande från det anmälda organet (Notified Body) att förlänga hållbarheten för sitt Covid-19-antigentest Regulatory MAR
2022-10-14 11:30 AegirBio tillkännager sin första kliniska saliv-TDM-studie i USA Regulatory
2022-10-14 11:30 AegirBio announces first clinical saliva TDM study in US Regulatory
2022-09-19 14:12 Korrigering av tidigare publicerad pressrelease om ny COO i AegirBio. Pressreleasen blev felaktigt märkt med hänvisning till lag om värdepappersmarknaden. Regulatory
2022-09-19 09:51 Nils Paulsson ny COO på AegirBio Regulatory
2022-09-06 20:11 VD Bradley Messmer kommenterar kvartalsrapporten
PreviousNext

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

Subscribe to our press releases

By clicking the Sign Up button, you agree to the privacy policy

en_USEN
en_USEN es_ESES
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.